| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| IVOR ROYSTON | Director | $665,407 | 25 Nov 2024 | ||
| Roger Pomerantz | Director | $105,837 | 25 Nov 2024 | ||
| Daniel R. Chevallard | CFO and COO | $91,896 | 12 Mar 2024 | ||
| Lisa Rojkjaer | Chief Medical Officer | $77,579 | 16 Mar 2023 | ||
| Mark Rothera | President and CEO, Director | $49,320 | 12 Mar 2024 | ||
| Jane Chung | Director | 20 Jun 2024 | |||
| Stephen Rubino | Director | 20 Jun 2024 | |||
| Barry J. Simon | Director | 20 Jun 2024 | |||
| Jane F. Barlow | Director | 20 Jun 2024 | |||
| THOMAS E. DARCY | Director | 20 Jun 2024 | |||
| Flavia Borellini | Director | 20 Jun 2024 | |||
| Michael E. Faerm | Chief Financial Officer | 14 May 2024 | |||
| Michael Huang | Director | 09 Jun 2022 | |||
| NICOLE ONETTO | Director | 09 Jun 2022 | |||
| Melody Burcar | Senior VP, Finance | 20 Mar 2024 | |||
| Darrel P. Cohen | Chief Medical Officer | 12 Mar 2024 | |||
| Samuel Lafayette Murphy | Director | 20 Jun 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|